E2F1-HMGCR轴促进免疫阻断性瘤细胞中的铁灭抵抗
Sung Wook Son1, Hyo-Jung Lee2,3,4, NaNa Kang1
1Department of Cell biology, Daegu Catholic University School of Medicine, Daegu, South Korea.
Nature communications
|December 3, 2025
概括
癌细胞通过上调HMGCR来抵抗免疫疗法,这是由E2F1.1.驱动的过程. 抑制HMGCR恢复了对癌症免疫疗法的敏感性,针对E2F1-HMGCR轴进行治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 细胞死亡机制 细胞死亡机制
背景情况:
- 癌细胞通过改变细胞死亡途径来逃避免疫反应.
- 铁亡,一种调节性亡的形式,对于抗瘤免疫是至关重要的.
- 免疫阻断性瘤中铁亡调节的机制尚未完全理解.
研究的目的:
- 为了研究瘤细胞在癌症免疫编辑过程中如何对铁灭产生抵抗力.
- 确定免疫疗法耐药瘤中铁灭性耐药性的基础分子机制.
- 探索E2F1-HMGCR轴作为治疗目标.
主要方法:
- 在PD-1阻塞和采用性T细胞疗法 (ACT) 后,利用了免疫阻断性瘤的临床前模型.
- 分析了E2F1和HMGCR在介导铁灭抵抗中的作用.
- 评估了HMGCR抑制在恢复免疫疗法敏感性的有效性.
主要成果:
- 基于T细胞的免疫疗法诱导瘤细胞中的铁灭性抵抗.
- 免疫疗法可提高E2F1的调节,从而增强HMGCR的表达,并促进铁灭菌的耐药性.
- 抑制HMGCR使免疫阻断性瘤对PD-1阻断和ACT重新敏感.
结论:
- 癌细胞通过通过E2F1-HMGCR通路调节铁亡来获得免疫疗法耐药性.
- E2F1-HMGCR轴代表了一个关键的分子标,用于克服耐火性癌症中耐火性耐火性.
- 向HMGCR可以使瘤对现有的免疫疗法重新敏感.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.6K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K


